Literature DB >> 10195343

Cannabis and schizophrenia: results of a follow-up study.

D Caspari1.   

Abstract

A total of 39 schizophrenic patients with a history of current cannabis abuse at index admission was compared with a control group of schizophrenics without substance abuse matched for age, gender, and year of admission. At follow-up after 68.7+/-28.3 months, 27/ 39 cases and 26/39 controls could be investigated. 8/27 cases (30%) had continued cannabis abuse, 6/27 (22%) had become alcohol abusers. Only one patient of the control group had started abusing alcohol. Patients with previous cannabis abuse had significantly more rehospitalizations, tended to worse psychosocial functioning, and scored significantly higher on the psychopathological syndromes "thought disturbance" (BPRS) and "hostility" (AMDP). These results confirm the major impact of cannabis abuse on the long-term outcome of schizophrenic patients.

Entities:  

Mesh:

Year:  1999        PMID: 10195343     DOI: 10.1007/s004060050064

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  33 in total

1.  Is there a role for marijuana in medical practice?

Authors:  Mark A Ware; Meldon Kahan; Anita Srivastava
Journal:  Can Fam Physician       Date:  2006-12       Impact factor: 3.275

2.  Is there a role for marijuana in medical practice? No.

Authors:  Meldon Kahan; Anita Srivastava
Journal:  Can Fam Physician       Date:  2007-01       Impact factor: 3.275

3.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Authors:  Daniel J Foti; Roman Kotov; Lin T Guey; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

4.  Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

Authors:  Pamela DeRosse; Alyson Kaplan; Katherine E Burdick; Todd Lencz; Anil K Malhotra
Journal:  Schizophr Res       Date:  2010-05-18       Impact factor: 4.939

Review 5.  The Epidemiology and Associated Phenomenology of Formal Thought Disorder: A Systematic Review.

Authors:  Eric Roche; Lisa Creed; Donagh MacMahon; Daria Brennan; Mary Clarke
Journal:  Schizophr Bull       Date:  2014-09-01       Impact factor: 9.306

6.  Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

Authors:  Inge Gorynia; Markus Schwaiger; Andreas Heinz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-05-04       Impact factor: 5.270

7.  Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder?

Authors:  Jules Angst; Alex Gamma; Jérôme Endrass; Wulf Rössler; Valdeta Ajdacic-Gross; Dominique Eich; Richard Herrell; Kathleen Ries Merikangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

8.  Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Authors:  Ana M Sánchez-Torres; Virginia Basterra; Araceli Rosa; Lourdes Fañanás; Amalia Zarzuela; Berta Ibáñez; Víctor Peralta; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-12       Impact factor: 5.270

9.  Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment.

Authors:  Stephen Magura; Andrew Rosenblum; Thomas Betzler
Journal:  Subst Abuse       Date:  2009-10-28

10.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.